March 25, 2020 / 10:09 AM / 16 days ago

BRIEF-Nu-Med Plus Closely Monitoring Outcomes On Two New Human Clinical Trials Using Inhaled Nitric Oxide In Treatment Of Covid-19

March 25 (Reuters) - Nu-Med Plus Inc:

* NU-MED PLUS CLOSELY MONITORING OUTCOMES ON TWO NEW HUMAN CLINICAL TRIALS USING INHALED NITRIC OXIDE IN TREATMENT OF COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below